Susan Bobulsky

Senior Vice President, Diagnostics, clonoSEQ

Susan Bobulsky is the Senior Vice President, Diagnostics, clonoSEQ of Adaptive Biotechnologies, a commercial-stage biotech company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease. Before this, she served in commercial and strategic planning roles of ascending responsibility since joining Adaptive in September 2014. Prior to joining Adaptive, Susan was an Associate Principal with ZS Associates, a healthcare management consulting firm, where she worked for nine years specializing in commercialization strategy and execution for therapeutic and diagnostic products. Susan holds an MBA from the Stanford Graduate School of Business and a BS in Science, Technology and Society from Stanford University.